Reuters Health Report

Click to View in Browser 02/3/2014 We can't beat cancer with drugs alone; prevention crucial: WHO LONDON (Reuters) - Governments must make better use of vaccines and preventative public health policies in the fight against cancer as treatment alone cannot stem the disease, a World Health Organization (WHO) agency said on Monday. Pfizer's new breast cancer drug succeeds in trial (Reuters) - Pfizer Inc's experimental breast cancer drug significantly improved patient survival rates in a mid-stage trial without their condition worsening, maintaining the company's lead in the race for a new treatment standard for the disease. More evidence HPV vaccine doesn't promote risky sex NEW YORK (Reuters Health) - Young women who get the human papillomavirus (HPV) vaccine don't see it as a license to have more sexual partners or forgo condoms, a new study confirms. Ablynx agrees Merck cancer deal worth up to 1.7 billion euros BRUSSELS (Reuters) - Belgian biotech company Ablynx has signed a deal with Merck & Co worth up to 1.7 billion euros ($2.3 billion) to develop ways of triggering the body to fight cancer by itself. Sisterhood shown to be powerful incentive at women's gyms NEW YORK (Reuters) - Women-only gyms, once seen as the exercise alternative for out of shape women of a certain age, are actively shedding that reputation, fitness experts say. Biogen multiple sclerosis drug Tecfidera wins European approval (Reuters) - Biogen Idec Inc's high profile new multiple sclerosis drug Tecfidera won European approval, the company said on Monday, opening the door for its launch in one of the world's largest markets for MS treatments. Given Imaging gets FDA clearance for colon camera pill JERUSALEM (Reuters) - Camera-in-a-pill maker Given Imaging said on Monday it received U.S. Food and Drug Administration clearance for a pill to provide visualization of the colon that has a global market of 3 million procedures a year. GSK to launch late-stage clinical trials on 10 new drugs: paper (Reuters) - GlaxoSmithKline is set to unveil plans to launch late-stage clinical trials on 10 new drugs over the next two years, the Telegraph reported, without citing sources. Study finds deregulation fuelling obesity epidemic LONDON (Reuters) - Governments could slow or even reverse the growing obesity epidemic if they introduced more regulation into the global market for fast foods such as burgers, chips and fizzy drinks, researchers said on Monday. Two Obamacare exchanges see more health insurer competition WASHINGTON (Reuters) - At least two U.S. states running their own Obamacare health insurance exchanges expect new insurers to enter their marketplaces and bolster competition in 2015, officials said on Friday. Related Video Keystone pipeline review shows little climate risk Flooding, winter storms wreak havoc across Europe The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend